- Trials with a EudraCT protocol (178)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
178 result(s) found for: Ventricle.
Displaying page 1 of 9.
EudraCT Number: 2011-001187-21 | Sponsor Protocol Number: SCRM-001 | Start Date*: 2011-11-28 | |||||||||||
Sponsor Name:University of Zurich | |||||||||||||
Full Title: A Phase I/II, Open Monocentric Study To Evaluate The Safety And Efficacy Of An Autologous Tissue-Engineered Vascular Graft In Peadiatric Patients Requiring Reconstruction Of Right Ventricle Outflow... | |||||||||||||
Medical condition: functional single ventricle physiology functional single left ventricle functional single right ventricle functional single biventricle | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Temporarily Halted) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002688-28 | Sponsor Protocol Number: 66/2007/U/Sper | Start Date*: 2007-05-22 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: Pilot study on the short-term effects of Sildenafil on hemodynamic response to exercise and exercise capacity in Fontan patients | |||||||||||||
Medical condition: congenital heart disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001787-71 | Sponsor Protocol Number: CCB-CRC-07-01 | Start Date*: 2008-02-11 |
Sponsor Name:Charité - Universitätsmedizin Berlin | ||
Full Title: The influence of Rimonabant induced cannabinoid receptor blocking on the mass and function of the left ventricle in patients with abdominal adiposity | ||
Medical condition: Adiposity is another risk factor for developing cardiac insufficiency and myocardial hypertrophy. Probably the volume loading of the left ventricle, systemic inflammation, the fatty degeneration of... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2006-002262-19 | Sponsor Protocol Number: CVAL489ANL09 | Start Date*: 2006-08-07 |
Sponsor Name:Novartis Pharma B.V. | ||
Full Title: Angiotensin II receptor blockers in patients with systemic right ventricle. | ||
Medical condition: Systemic right ventricle due to total transposition of the great arteries or congenitally corrected transposition of the great arteries | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-004291-21 | Sponsor Protocol Number: 33IC30_166855 | Start Date*: 2018-01-15 |
Sponsor Name:Insel Gruppe AG - Inselspital Universitätsklinik für Kardiologie | ||
Full Title: Effect of phosphodiesterase-5 inhibition with Tadalafil on SystEmic Right VEntricular size and function – a multi-center, double-blind, randomized, placebo-controlled clinical trial – SERVE Trial | ||
Medical condition: Adults with congenital heart disease (CHD) and a right ventricle (RV) in subaortic (systemic) position. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-000266-37 | Sponsor Protocol Number: Version7-20/12/2018 | Start Date*: 2019-06-21 |
Sponsor Name:Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal | ||
Full Title: Randomized clinical trial to evaluate the efficacy and safety of the treatment with supplementary oxygen in patients with Intermediate-Risk pulmonary embolism (PE) | ||
Medical condition: Acute symptomatic pulmonary embolism | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002610-76 | Sponsor Protocol Number: 39039039CHD3001/BAY59-7939-18226 | Start Date*: 2016-09-21 | |||||||||||
Sponsor Name:Janssen-Cilag International N.V | |||||||||||||
Full Title: A Prospective, Open-Label, Active-Controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Rivaroxaban for Thromboprophylaxis in Pediatric Subjects 2 to 8 Years ... | |||||||||||||
Medical condition: thromboprophylaxis | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) FR (Completed) ES (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004063-31 | Sponsor Protocol Number: FIM-PRELEVD-2018-01 | Start Date*: 2019-04-26 |
Sponsor Name:Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS) | ||
Full Title: Mechanisms of cardio and nephroprotection in patients who are going on cardiac surgery with right ventricular dysfunction, with preoperative treatment of levosimendan compared with placebo. (PREL... | ||
Medical condition: Perioperative right ventricle dysfunction | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002580-85 | Sponsor Protocol Number: 3d | Start Date*: 2005-08-08 |
Sponsor Name:Rigshospitalet | ||
Full Title: Acute haemodynanic effects of Treatment with ACE inhibitores in patients with severe Aortic Stenosis | ||
Medical condition: Aortic valve stenosis is a reduction of the aortic valve orifice to a degree where emptying of the left ventricule is compromised. The two major causes for aortic valve stenosis is calcific valve d... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-010594-20 | Sponsor Protocol Number: P 0901 | Start Date*: 2010-04-13 |
Sponsor Name:LUMC | ||
Full Title: Thoracic epidural anesthesia with ropivacaine: effects of age on neural blockade and cardiovascular parameters | ||
Medical condition: Medical conditions will not be investigated per se, however we will study the effect of standard thoracic epidural anesthesia on specific age groups undergoing lung surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-015826-13 | Sponsor Protocol Number: Q-10 | Start Date*: 2010-10-07 | |||||||||||
Sponsor Name:PROF. TIZIANO GHERLI | |||||||||||||
Full Title: THE USE OF COENZYME Q 10 BEFORE HEART SURGERY IN ELDERLY PATIENTS. | |||||||||||||
Medical condition: Patients (male or female) aged > 70 years, clinically stable, with a diagnosis of severe aortic stenosis with indication to surgery based on echocardiography and left ventricle angiography. | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-005898-29 | Sponsor Protocol Number: RRK2962 | Start Date*: 2008-07-04 | |||||||||||||||||||||
Sponsor Name:University Hospital Birmingham | |||||||||||||||||||||||
Full Title: The effect of bosentan, a selective endothelin antagonist, on cardiovascular performance in patients with a Fontan circulation | |||||||||||||||||||||||
Medical condition: Patients with a Fontan circulation (that is they have had a Fontan operation for a functionally univentricular heart) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001659-10 | Sponsor Protocol Number: S55481 | Start Date*: 2013-08-08 | |||||||||||
Sponsor Name:UZLeuven | |||||||||||||
Full Title: Acute effects of Sildenafil on the hemodynamics, Right Ventricle performance and cyclic GMP concentration in Heart failure patients with preserved left ventricular ejection fraction and patients af... | |||||||||||||
Medical condition: To investigate acute effects of sildenafil on cardiac hemodynamics, right ventricle performance and cGMP concentrations in heart failure patients with preserved ejection fraction and patients after... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002821-45 | Sponsor Protocol Number: AC-055H302 | Start Date*: 2019-03-05 | ||||||||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd | ||||||||||||||||||
Full Title: Prospective, multi-center, single-arm, open-label long-term study assessing the safety, tolerability, and effectiveness of macitentan in Fontan-palliated adult and adolescent subjects | ||||||||||||||||||
Medical condition: Congenital Heart Failure | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Completed) DE (Completed) GB (GB - no longer in EU/EEA) DK (Completed) PL (Completed) CZ (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-000752-18 | Sponsor Protocol Number: 17-924 | Start Date*: 2019-02-19 |
Sponsor Name:UMC Utrecht | ||
Full Title: Ajmaline provocation in asymptomatic PLN and PKP2 mutation carriers for early detection of Arrhythmogenic Cardiomyopathy | ||
Medical condition: Arrhythmogenic cardiomyopathie due to PLN or PKP2 mutations, asymptomatic family members who are carriers of PLN or PKp2 mutations, patients without structural heart disease who are referred for aj... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004662-25 | Sponsor Protocol Number: AMI-Study | Start Date*: 2017-10-18 | |||||||||||
Sponsor Name:Krakowski Szpital Specjalistyczny im. Jana Pawła II | |||||||||||||
Full Title: Regeneration of ischemic damages in cardiovascular system using Wharton’s jelly as an unlimited source of mesenchymal stem cells for regenerative medicine. Project of the National Centre for Resear... | |||||||||||||
Medical condition: AMI: Acute Myocardial Infarction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-002813-33 | Sponsor Protocol Number: ARMYDA-9DAPAtrial | Start Date*: 2023-02-21 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERO UNIVERSITARIA MAGGIORE DELLA CARITà DI NOVARA | ||||||||||||||||||
Full Title: Early use of dapaglifozin in diabetic patients with acute myocardial infarction and reduced ejection fraction: the randomized ARMYDA-9 DAPA trial | ||||||||||||||||||
Medical condition: Patients with type 2 diabetes and ST-elevation myocardial infarction treated with primary primary percutaneous coronary intervention and reduced left ventricle ejection fraction. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-005394-66 | Sponsor Protocol Number: ESR-20-21070 | Start Date*: 2022-02-21 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA SENESE | |||||||||||||
Full Title: Effects of Dapagliflozin on cardiac deformation and clinical outcomes in heart failure with reduced and mildly reduced ejection fraction | |||||||||||||
Medical condition: heart failure with left ventricular ejection fraction <50% | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000661-20 | Sponsor Protocol Number: ICO | Start Date*: 2019-05-31 |
Sponsor Name:Vilnius University Hospital Santaros klinikos | ||
Full Title: Ivabradine to prevent anthracycline-induced cardiotoxicity: a prospective randomized open label clinical trial. | ||
Medical condition: Cancers treated with anthracyclines: leukemias, limphomas, breast, stomach, uterine, ovarian, lung. | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: LT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003320-23 | Sponsor Protocol Number: AC-055H301 | Start Date*: 2017-10-11 | ||||||||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd | ||||||||||||||||||
Full Title: Prospective, multi-center, double-blind, randomized, placebo-controlled, parallel-group study assessing the efficacy and safety of macitentan in Fontan-palliated adult and adolescent subjects. | ||||||||||||||||||
Medical condition: Congenital Heart Failure | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Completed) DK (Completed) FR (Completed) PL (Completed) IE (Completed) CZ (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.